Page 1

Cipher Announces Third Quarter and Year - to- Date 2021 Financial Results • Revenue for nine months ended September 30 , 2021increases 4.1 % to $ 16.1 million Adjusted EBITDA¹ for nine months ended September 30 , 2021 increases to $ 9.8 million • Basic EPS for the nine months ended September 30 , 2021 increases 12 % to $ 0.19 ( CDN $ 0.242 ) Excluding one - time charges , EPS for the nine months ended September 30 , 2021 was $ 0.263 ( CDN $ 0.33 ) • The Canadian product revenue increased 30 % during the nine months ended September 30 , 2021 compared to the similar period in 2020 . • During the quarter , the Company assigned the office lease for its corporate head office which will result in a savings of CAD $ 2.2 million over the remainder of the lease term . OAKVILLE , ON , Nov. 11 , 2021 / CNW / - Cipher Pharmaceuticals Inc. ( TSX : CPH ) ( " Cipher " or " the Company " ) today announced its financial and operating results for the three and nine months ended September 30 , 2021. Unless otherwise noted , all figures are in U.S. dollars . Year - to - Date ( Nine months ended September 30 , 2021 ) Financial Highlights ( All figures in U.S. dollars , compared to nine months ended September 30 , 2020 , unless otherwise noted ) • Total revenue increased 4.1 % to $ 16.1 million compared to $ 15.5 million • SG & A decreased 7 % to $ 4.1 million compared to $ 4.4 million • Adjusted EBITDA1 increased to $ 9.8 million • Basic EPS increased 12 % to $ 0.19 compared to $ 0.17 • Excluding one - time charges , basic and diluted EPS was $ 0.263 ( CDN $ 0.33 ) compared to basic and diluted EPS of $ 0.17 and $ 0.16 respectively • As at September 30 , 2021 , the Company had $ 15.6 ( CDN $ 19.9 ) million in cash or $ 0.59 per share ( CDN $ 0.75 ) • Normal Course Issuer Bid 864,100 shares repurchased and cancelled to the end of September 30 , 2021 Q3 2021 Financial Highlights ( All figures are in U.S. dollars ) • Total revenue $ 4.5 million compared to $ 4.8 million in Q3 2021 • Adjusted EBITDA decreased to $ 2.2 million compared to $ 2.8 million • Basic EPS $ 0.03 compared to $ 0.06 • Excluding one - time charges , basic and diluted EPS for the three months ended September 30 , 2021 was $ 0.064 ( CDN $ 0.08 ) compared to $ 0.06 in Q3 2020 • Normal Course Issuer Bid 233,100 shares repurchased and cancelled during the three months ended September 30 , 2021 Management Commentary Craig Mull , Interim CEO commented , " Our year - to - date results continue to trend positively . Revenue , Adjusted EBITDA and EPS all showed growth compared to the same period last year . We generated $ 8.1 million in cash from operating activities in the nine months ending September 30 , 2021 , ending the period with $ 15.6 million in cash , placing us in an excellent position as we continue to actively pursue profitable growth opportunities and maximize the income generated from our distribution agreements . "